A growing body of research demonstrates significant discoveries and advancements in knowledge into potential biomedical strategies for reversing the aging process. Today, researchers continue to study animal and human abilities to regenerate cells, aiming to diminish cognitive decline, immune system weakening, and other adverse effects of the biological aging process. Meanwhile, healthcare and biotech companies race to “find the key” to reversing the aging process, bringing the market valuation of anti-aging medicine to a projected $610 billion by 2025 from current estimates of $110 billion. Investors are pouring millions into start-up companies that focus on anti-aging and regenerative medical research, in hopes of being the first organization to make a breakthrough – bringing a successful solution to aging to the public.
November 8, 2019